Truffle Capital Unveils the Results of the 14th Truffle 100 Ranking: Software Companies Approach the Next Investment Cycle With Confidence
Truffle Capital unveils the results of its 14th Truffle 100 ranking. This is the barometer that is most frequently followed by software companies, and the most consistent software trends observatory.
Carried out in partnership with Teknowlogy, the study paints a picture of a group of French companies in good health, with good growth prospects, looking to the future with confidence.
- Confidence in the future, because software companies are continuing to invest heavily in R&D and, in anticipation of future growth, are recruiting researchers.
- Confidence in the potential of the French ecosystem, as 75% of managers surveyed do not expect to relocate their business (compared to 70% last year).
- Confidence in their capacity to find finance for their growth plans. The numerous delistings show that software companies are finding the investment resources they need in other finance niches, where procedures take better account of the valuations and specific features of their operations.
While growth in turnover was only 3%, taking it to €9.3 billion, with investment of €1.2 billion in R&D over the year, profits increased by 4.6%. These figures show that the long history of almost uninterrupted growth highlighted by the Truffle 100 since 2004 is continuing.
Dassault Systèmes, Sopra Steria and Murex take the top three spots in the ranking, accounting between them for total turnover from publishing of €5.4 billion, and reflecting a trend towards consolidation within the sector.
Disaffection with the stock exchange is apparent. Since 1 January 2019, we have seen the exit of Harvest (in 52nd place) and Coheris (in 78th place), bringing the number of listed companies down to 14, its lowest historic level since the creation of the Truffle 100.
Bernard-Louis Roques, General Manager and Co-founder of Truffle, commented on the results: 'Business growth demonstrates that the sector is highly resilient. Not only are French software companies growing more rapidly than GDP, but their investment in jobs and R&D is growing faster than their sales. This continuous focus on investment, particularly in research, and the resistance to relocation are helping French technology to flourish, translating into confidence in its ability to build future growth. From this viewpoint, the fact that ten of them have been delisted over two years reflects two things: software companies are not satisfied with the valuation the market gives them, and they know they are supported by strategic shareholders, particularly from the private equity sphere, who are ready to invest. No doubt many surprises lie in store over the coming years, and Truffle Capital, through the Truffle 100, will be best placed to monitor them.'
The 14th edition of the Truffle 100, and rankings from previous years, are available at:
https://www.truffle100.com/index.html
******
About Truffle Capital
Established in 2001, Truffle Capital is an independent European venture capital company, specializing in life sciences (BioTech and MedTech) and breakthrough technologies in the IT sectors (FinTech and InsurTech). Truffle Capital’s mission is to support the creation and development of young innovative companies capable of becoming tomorrow’s leaders. Headed by Patrick Kron, alongside Dr Philippe Pouletty and Bernard-Louis Roques, Co-founders and General Managers, Truffle Capital manages assets of €500 million. Since it was created, it has raised nearly €1 billion and has supported over 75 companies in the digital technology and life sciences sectors. At the end of 2017, Truffle Capital successfully closed its first two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, and also closed an RIF (retirement income fund).
For more information: www.truffle.com – Twitter: @trufflecapital
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005314/en/
Contact information
Maud Lazare | maud@truffle.com
DGM Conseil | +33 1 40 70 11 89
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse ® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 09:58:00 EEST | Press release
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause of disability and death. AD develops over many years, long before symptoms are evident, but the lack of accessible, minimally invasive diagnostics results in many patients remaining undiagnosed until the disease is well advanced, when few effective interventions remain. The Lumipulse G pT
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes17.5.2025 00:17:00 EEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 16:00:00 EEST | Press release
Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Or
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 13:47:00 EEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 13:30:00 EEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom